Janus Henderson Investors US’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Janus Henderson Investors US’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-590,337	Closed	-$102M	–	1176
2015 Q1	$102M	Sell	590,337 -1,020,311	-63%	-$150M	0.08%	308
2014 Q4	$185M	Buy	1,610,648 +1,493,948	+1,280%	+$181M	0.16%	177
2014 Q3	$18.2M	Buy	116,700 +27,200	+30%	+$3.94M	0.02%	594
2014 Q2	$11M	Sell	89,500 -161,516	-64%	-$17.9M	0.01%	659
2014 Q1	$26M	Sell	251,016 -60,562	-19%	-$6.2M	0.02%	515
2013 Q4	$28M	Sell	311,578 -71,944	-19%	-$5.74M	0.03%	489
2013 Q3	$25.6M	Buy	383,522 +130,634	+52%	+$9M	0.03%	490
2013 Q2	$16.7M	Buy	+252,888	New	+$14.5M	0.02%	526

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Janus Henderson Investors US's SLXP Position: Q2 2015 in Review

Janus Henderson Investors US sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 590,337 shares — an estimated $102M sold.

Janus Henderson Investors US first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $185M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Janus Henderson Investors US reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Janus Henderson Investors US sold 590,337 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $102M.
Janus Henderson Investors US first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Janus Henderson Investors US's SALIX PHARMACEUTICALS LTD DEL position peaked at $185M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Janus Henderson Investors US's 13F filing for Q2 2015, filed 17 Aug 2015.